NORSK MEDISINALDEPOT AS

Org. no. 965336796 · OSLO · Founded 1992 · 3,702 employees

Score · fiscal year 2025

51of 100

How to read this: the company is ahead of 55 % of large companies in the same sector in 2025. What does this mean?

Rank: 18,886 of 38,670 · Handel

Profile

Cheetah · Sprinter

High profitability, lower solidity

Position against comparable companies in 2025, not a verdict on the company. Based on profitability 71 and solidity 38 out of 100 among large companies in the same sector in 2025. Methodology

Against the sector

NORSK MEDISINALDEPOT AS is 1 points above the median for large companies in the same sector in 2025.

Median score 50 among 362 companies.

Against large companies in the same sector in 2025: operating margin 4.3% (median 2.1%) and equity ratio 24.8% (median 34.6%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 28 October 2026Report an issue
Key figures · 2025

The numbers behind the score

The numbers behind the score · 2025
MeasureCompanyMedianAhead of
Operating revenue11,907 MNOK2,073 MNOK
Operating margin 4.3% 2.1% 76 %
Profit margin 4.4% 2.1% shown, not part of the index
Return on assets 11.9% 8.4% 66 %
Equity ratio 24.8% 34.6% 38 %
Debt-to-equity 3.03 1.85 37 %
Current ratio 0.93 1.27 12 %
Revenue growth 9.0% 6.5% 63 %
Revenue per employee3.22 MNOK15.47 MNOK

The median and “ahead of” refer to large companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.

With an index of 51, NORSK MEDISINALDEPOT AS does better than 55% of large companies in the same sector (362 companies) in 2025.

Over time

Score 2024–2026

CompanyMedian0255075100202420252026
  • NORSK MEDISINALDEPOT AS
  • Median: large companies in the same sector
Summary analysis

NORSK MEDISINALDEPOT AS has a score of 51 for 2025, rank 18,886 of 38,670 in the sector.

Strongest: Profitability: percentile 71 against peers, operating margin 4.3% against a median of 2.1%. Growth: percentile 63 against peers, revenue growth 9.0% against a median of 6.5%.

Weakest: Liquidity: percentile 12 against peers, current ratio 0.93 against a median of 1.27. Solidity: percentile 38 against peers, equity ratio 24.8% against a median of 34.6%.

Worth a closer look

Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made

Analysis · 2025

What the numbers say

NORSK MEDISINALDEPOT AS had an operating margin of 4.3% and an equity ratio of 24.8% in 2025, and ranks 18,886 of 38,670 in Handel.

From 2024 to 2025: the equity ratio rose from 18.5% to 24.8%.

This text is generated automatically from the 2025 accounts.

Estimated value · 2025

Three simple methods

The methods give between 1,107 MNOK and 5,180 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 399.8 MNOK 10.0 3,998 MNOK
EV/EBIT Operating profit: 516.8 MNOK
minus net debt −1,045.3 MNOK
8.0 5,180 MNOK
P/B Equity: 1,107.0 MNOK 1.0 1,107 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2025

Worth a closer look

  • watch

    Consider strengthening liquidity: current liabilities are 1.1 times current assets.

    Based on: Current ratio 0.93 (median 1.27).

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 0.2% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

Data quality

No anomalies found in the figures.

Stress test · 2017

Scenario analysis: the sector's weakest year

We have no accounts for 2017, the sector's weakest year, for this company.

The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2025

What the score is made of

Profitability71 weight 30%
Solidity38 weight 25%
Liquidity12 weight 15%
Growth63 weight 15%
Consistency58 weight 15%

Durability: 45 (average over 2 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2025

Questions and answers

How profitable is NORSK MEDISINALDEPOT AS?

The operating margin was 4.3% in 2025, against a median of 2.1% among large companies in the same sector. Return on assets was 11.9%.

How solid is NORSK MEDISINALDEPOT AS?

The equity ratio was 24.8% in 2025 (median 34.6%). Debt-to-equity was 3.03 (median 1.85).

What is the liquidity of NORSK MEDISINALDEPOT AS like?

The current ratio was 0.93 in 2025 (median 1.27). Current assets did not cover current liabilities.

How does NORSK MEDISINALDEPOT AS compare in Handel?

NORSK MEDISINALDEPOT AS ranks 18,886 of 38,670 in Handel for 2025. Among companies of the same size (large companies) it ranks 163 of 362. Revenue changed by 9.0% from the year before.

Public contracts

Contracts awarded since 2024
5
Total awarded value since 2024
value not stated
1 contracts without a stated value are not in the total.
Framework agreements
4
Left out of the total: the value is a ceiling, not actual spend.
DateBuyerNotice ValueCPV
13 April 2026 Trondheim kommune Legemiddel og multidose (Storby 2) 1,650.0 MNOK (framework) 33600000
6 March 2026 Arendal kommune Rammeavtale Legemidler og multidose - Arendal kommune 2025 12.0 MNOK (framework) 33600000
3 February 2026 Sunnfjord kommune Legemidler og multidose, rammeavtale 18.0 MNOK (framework) 33600000
3 February 2025 Vestfold fylkeskommune Apotekvarer Tannhelse value not stated 33600000
21 November 2024 AVINOR AS Oslo lufthavn: Leie av areal for utøvelse av forretningsvirksomhet innenfor apotek value not stated 85000000
11 December 2023 Regionalt Innkjøp i Kongsvingerregionen Kontraktstildeling: Legemidler, multidoser og farmasøytiske tjenester til kommunene i Kongsvingerregionen 2023-2027 35.1 MNOK (framework) 33600000
1 November 2023 Ørland kommune Åpen anbudskonkurranse - legemidler og multidose 3.0 MNOK (framework) 33600000
19 October 2023 Vestland fylkeskommune Rammeavtale for anskaffing av dentale legemiddel - apotekvarer til tannhelsetenesta 8.0 MNOK 33000000
4 October 2023 UNIVERSITETET I BERGEN ANSK-23-0082 Legemidler, vaksiner og andre apotekvarer 0.0 MNOK 33600000
18 October 2022 Universitetet i Oslo Medikamenter/Legemidler 0.2 MNOK 33000000

Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.

Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.

Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0

From the Central Coordinating Register

Org. no.
965336796
Legal form
AS
Sector
Handel (47.730)
Size tier
large
Employees
3,702 registered 10 October 2026
Founded
15 November 1992 33 years in operation
Share capital
300.40 MNOK
Business address
Alf Bjerckes vei 28, 0582 OSLO
Municipality
Oslo rank 63–221 of 357 in Norway
Latest accounts filed
2026
Website
www.vitusapotek.no
LEI
529900PPZ8FF0RXJ2T05 not renewed (lapsed)

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Chief executive
Rune Spikseth
Chair of the board
Runar Hollevik
Board member
Truls Fjeldstad
Board member
Margrethe Sunde
Board member
Øyvind Andersen
Board member
Mette Lier
Board member
Anita Sveum Nilsen
Board member
Tom Henry Nessen Baug
Board member
Piotr Lechowski
Deputy member
Tommy Hjortsberg
Deputy member
Camilla Rummelhoff
Deputy member
Christian Nordby
Deputy member
Kristin Hexeberg Berntsen
Deputy member
Cathrine Lien Rønningen
Deputy member
Csaba Pataki
Deputy member
Muhammad Aitzaz Islam
Auditor
DELOITTE AS
Accountant
VISMA ENTERPRISE AS

Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.

Parent company
Parent not made public

Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 29 October 2026. The parent is the one the company itself reported to GLEIF.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 28 October 2026.

Details

Year by year · 2024–2026

Key figure202420252026Trend
Index405153
Rank25,26118,88693
Operating margin5.1%4.3%5.1%
Return on assets15.9%11.9%16.8%
Equity ratio18.5%24.8%29.1%
Current ratio0.780.930.92
Revenue growth–9.0%7.2%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202420252026
Operating revenue10,921.4 MNOK11,907.1 MNOK12,766.7 MNOK
Operating profit559.4 MNOK516.8 MNOK647.8 MNOK
Profit before tax560.0 MNOK527.2 MNOK658.9 MNOK
Net profit427.8 MNOK399.8 MNOK500.7 MNOK
Financial expenses23.4 MNOK5.2 MNOK7.3 MNOK
Total assets3,664.2 MNOK4,465.2 MNOK3,969.4 MNOK
Current assets2,317.7 MNOK3,073.5 MNOK2,516.3 MNOK
Equity677.6 MNOK1,107.0 MNOK1,155.7 MNOK
Retained earnings58.5 MNOK60.8 MNOK109.6 MNOK
Total liabilities2,986.6 MNOK3,358.3 MNOK2,813.6 MNOK
Current liabilities2,966.9 MNOK3,320.0 MNOK2,740.2 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 28 October 2026, accounts id 6123521.

Similar companies